NH Attorney General Announces $200 Million Dollar Settlement

Attorney General Michael A. Delaney announced Thursday that after an extensive four-year investigation, he and 35 other Attorneys General have reached a $200 million dollar settlement with Janssen Pharmaceuticals, Inc. A complaint filed Thursday, alleged that Janssen engaged in unfair and deceptive practices when it marketed Risperdal for unapproved or off-label uses for both geriatric and pediatric populations, targeting patients with Alzheimer’s disease, dementia, depression, and anxiety Risperdal is among a class of drugs known as atypical or second-generation antipsychotics.
Federal Law prohibits pharmaceutical manufacturers from promoting their products for off-label uses.
Janssen has agreed to change how it promotes and markets its atypical anti-psychotics drugs and to refrain from any false, misleading or deceptive promotion of them.

Tagged with: ,
Posted in Uncategorized

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>